Skip to main content
Main menu
Pipeline
Clinical
Discovery
Compounds
Regimens
Drug Targets
Developers
Trial Sites
Trials
News
Meetings
Members
Our Members
Core Group
About
Join Us
Trial
Phase 2 Placebo-controlled, Randomized Study of Oral Immunomodulator in TB and TB/HIV Patients
Study Director
Start Date
11 / 2010
Trial Phase
Trial Status
enrolling
Current Enrollment
0
Target Enrollment
120
Overview
Compound Associations
Adjunct immunotherapy